Session 2: Pharmacotherapy Of Central Nervous System Disorders: Part 2-Sleeping Disorders, Anxiety Disorders

Date: 10/21/2010 Check-In and Breakfast:
7:00 am - 7:30 am
Educational Session: 7:30 am - 12:30 pm
Edward Fisher, Ph.D.,R.Ph. Professor of Pharmacology and Toxicology and Associate Dean for Academic Affairs University of Hawaii at Hilo College of Pharmacy 	
, Live CME Instructor for University Learning Systems
Edward Fisher, Ph.D.,R.Ph. Professor of Pharmacology and Toxicology and Associate Dean for Academic Affairs University of Hawaii at Hilo College of Pharmacy

Disclosure: Dr. Fisher  has no financial arrangements with any corporate organization that might have an interest in the subject being presented.

At the conclusion of this presentation, the participant should be able to:

  • Describe the distinguishing factors that are associated with various types of sleeping and anxiety disorders.
  • State the diagnostic criteria used for sleeping and anxiety disorders.
  • Describe the current theories on the etiology of sleeping and anxiety disorders.
  • Describe the various clinical symptoms associated with the disease states discussed.
  • Discuss the prognosis and epidemiology of the disease states discussed.
  • Describe how to implement a current medical treatment of the disease states discussed.
  • State the pharmacological properties of the drugs used to treat these disorders.
  • List the adverse effects associated with the drugs commonly used to treat these disorders.
[an error occurred while processing this directive]